We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$45.1M
1-Year Est. Return
74.25%
This Fund
S&P 500
This Quarter
Est. Return
-32.59%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$186M
AUM Growth
+$37.7M
(+25%)
Cap. Flow
+$6.03M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
97.73%
Holding
62
New
23
Increased
10
Reduced
8
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SUNE
SUNation Energy
SUNE
|
+$2.73M |
| 2 |
EMPD
Empery Digital
EMPD
|
+$1.64M |
| 3 |
Haoxi Health Technology Ltd
HAO
|
+$1.28M |
| 4 |
HCWC
Healthy Choice Wellness
HCWC
|
+$954K |
| 5 |
Elevai Labs
ELAB
|
+$927K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Scientific Inc Tranche 1 Warrants
CORZW
|
+$762K |
| 2 |
RDHL
Redhill Biopharma
RDHL
|
+$497K |
| 3 |
Greenwave Technology Solutions
GWAV
|
+$406K |
| 4 |
Eltek
ELTK
|
+$396K |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$304K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.32% |
| 2 | Technology | 0.49% |
| 3 | Consumer Discretionary | 0.43% |
| 4 | Consumer Staples | 0.4% |
| 5 | Materials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gevo
GEVO
$363M
| – | – |
-250,000
| Closed | -$139K |
|
|
52
Greenwave Technology Solutions
GWAV
$2.06M
| – | – |
-2,086
| Closed | -$406K |
|
53
InMed Pharmaceuticals
INM
$8.92M
| – | – |
-15,362
| Closed | -$81.6K |
|
|
54
iShares Russell 2000 ETF
IWM
$80.4B
| – | – |
-1,500
| Closed | -$304K |
|
|
LIPO
55
DELISTED
Lipella Pharmaceuticals
LIPO
| – | – |
-67,531
| Closed | -$243K |
|
|
RDHL
56
Redhill Biopharma
RDHL
$4.44M
| – | – |
-53,648
| Closed | -$497K |
|
|
RVPH
57
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| – | – |
-11,850
| Closed | -$263K |
|
|
SBFM
58
Sunshine Biopharma
SBFM
$3.04M
| – | – |
-100
| Closed | -$8.35K |
|
|
SCNI
59
Scinai Immunotherapeutics
SCNI
$1.36M
| – | – |
-17,828
| Closed | -$49.6K |
|
|
SONN
60
DELISTED
Sonnet BioTherapeutics
SONN
| – | – |
-29,799
| Closed | -$223K |
|
|
NEXI
61
DELISTED
NexImmune, Inc. Common Stock
NEXI
| – | – |
-49,904
| Closed | -$138K |
|
|
SMFL
62
DELISTED
Smart for Life, Inc. Common Stock
SMFL
| – | – |
-34,504
| Closed | -$102K |
|
Similar funds
CG
OC
ICCON
PCM
CAS
CM
MCMC
CTC
Sabby Management's Q3 2024 Portfolio in Review
As of Q3 2024, Sabby Management held 62 positions worth $186M, up 25% from $149M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Sabby Management deployed $6.03M of net new capital in Q3 2024, opening 23 new positions and adding to 10 existing holdings. Its largest new stake was SUNation Energy: 278 shares worth $373K.
By sector, the portfolio is most concentrated in Healthcare at 2.3% of assets, down from 3.5% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Sidus Space, an estimated $145K trimmed.
- Sabby Management's largest Q3 2024 buy was SUNation Energy: 278 shares worth $373K.
- Sabby Management added most to Ensysce Biosciences in Q3 2024, an estimated $343K increase.
- Sabby Management's biggest Q3 2024 reduction was Sidus Space, cutting an estimated $145K.
- Sabby Management fully exited Core Scientific Inc Tranche 1 Warrants in Q3 2024, selling an estimated $762K.
- Sabby Management's ten largest holdings make up 98% of its $186M portfolio in Q3 2024.
- Sabby Management opened 23 new positions and closed 20 in Q3 2024.
- Sabby Management's portfolio value rose 25% quarter-over-quarter to $186M.
Based on Sabby Management's 13F filing for Q3 2024, filed 14 Nov 2024.